{"SPADE_N_14427": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14427", "Peptide Name": "VM-3Y (VM P3Y analog, Leu-rich, synthetic AMPs, XXA, UCLL1c; BBMm)", "Source": "amino acid substitution, insects, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FLYIIGKLLSGLL", "Sequence Length": 13, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-MRSA", "Antibiofilm"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1449.82, "PI": 8.59, "Hydrophobicity": 1.85, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Zhang J, Sun R, Chen Z, Zhou C, Ma C, Zhou M, Chen X, Chen T, Shaw C, Wang L.2022", "Reference": "Biology (Basel). 2022 Aug 25;11(9):1263. doi: 10.3390/biology11091263.PubMed", "Title": "Evaluation of the Antimicrobial Properties of a Natural Peptide from Vespa mandarinia Venom and Its Synthetic Analogues as a Possible Route to Defeat Drug-Resistant Microbes."}], "Frequent Amino Acids": "LGI", "Absent Amino Acids": "ACDEHMNOPQRTUVW", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 3, "Positive Residues": 1, "Negative Residues": 0, "Net Charge": 1, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (92.31%) toVCP-VT1 or VML: 38%, G=I: 15%.Activity: Active against Gram+ S. aureus NCTC 6538 or MRSA ATCC 12493 (MIC 2 uM), E. faecalis NCTC 12697 (MIC 4 uM), Gram- E.coli ATCC 8739 (MIC >512 uM), K.pneumoniae ATCC 43816 (MIC >512 uM), P.aeruginosa ATCC 9027 (MIC >512 uM), and yeast C.albicans ATCC 10231 (MIC >512 uM).  Also inhibited biofilms:bacteria:S. aureus (MBIC 2 uM; MBEC 64-128 uM); biofilms:bacteria:E. faecalis (MBIC 64 uM).MOA:bacteria:S. aureus: it permeabilized bacterial membranes (2xMIC, 50%).Structure:  some structure in 10 mM NH4Ac and helical in 50% TFE/NH4Ac.In vitro toxicity: horse RBC: HC50 211.2 uM, less hemo.lytic.Animal model:wax moth: survival study: it protected the worms from death in a dose-dependent manner.Resistance development:no:bacteria:S. aureus: no resistance development after 16 cycles of passages. MIC changed 2 fold.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_25819", "Similarity": 1.0, "Sequence": "FLYIIGKLLSGLL"}, {"SPADE_ID": "SPADE_N_09179", "Similarity": 1.0, "Sequence": "GLLKRIKLLL"}, {"SPADE_ID": "SPADE_N_10984", "Similarity": 1.0, "Sequence": "GLLRIKLL"}]}}}